J
Jennifer L. Beebe-Dimmer
Researcher at Wayne State University
Publications - 92
Citations - 2395
Jennifer L. Beebe-Dimmer is an academic researcher from Wayne State University. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 26, co-authored 92 publications receiving 1820 citations.
Papers
More filters
Journal ArticleDOI
The Epidemiology and Pathogenesis of Neoplasia in the Small Intestine
TL;DR: The pathophysiology of Crohn inflammatory bowel disease and the elevated risk of adenocarcinoma demonstrate the significance of the impaired integrity of the mucosal barrier and of aberrant immune responses to luminal indigenous and potentially pathogenic microorganisms.
Journal ArticleDOI
Current Perspective on the Global and United States Cancer Burden Attributable to Lifestyle and Environmental Risk Factors
TL;DR: It is estimated that a maximum of 60% of cancer deaths in the United States may be attributed to eight risk factors: tobacco, alcohol, ionizing and solar radiations, occupations, infectious agents, obesity, and physical inactivity.
Journal ArticleDOI
Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013
Alison L. Van Dyke,Meredith S. Shiels,Gieira S. Jones,Ruth M. Pfeiffer,Jessica L. Petrick,Jennifer L. Beebe-Dimmer,Jill Koshiol +6 more
TL;DR: A recent US study reported increasing GBC incidence among people younger than 45 years and blacks; however, it did not examine trends for other biliary tract sites.
Journal ArticleDOI
Risk of second primary tumors in men diagnosed with prostate cancer: A population‐based cohort study
TL;DR: The survival of men diagnosed with prostate cancer has improved over time, and the current 10‐year relative survival rate is 99.7%.
Journal ArticleDOI
Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-Medicare investigation of treatment patterns and overall survival.
Jennifer L. Beebe-Dimmer,Jon P. Fryzek,Cecilia L. Yee,Tapashi Dalvi,David H. Garabrant,Ann G. Schwartz,Shirish M. Gadgeel +6 more
TL;DR: Irrespective of surgical resection, mesothelioma patients receiving some form of chemotherapy survived longer than patients who did not, with an additional survival benefit among those patients receiving multimodal treatment.